demyelinating diseases
Pipeline
Our fields of research
Myelin repair for demyelinating diseases
Tasronetide (FTX 101)
Chronic Optic Neuropathy
Tasronetide (FTX-101)
Multiple Sclerosis
Undisclosed Target
Multiple Sclerosis
Discovery | Candidate | IND-enabling | Phase 1 |
Tasronetide (FTX 101) – Chronic Optic Neuropathy
Phase 1
Tasronetide (FTX-101) – Multiple Sclerosis
Phase 1
Undisclosed Target – Multiple Sclerosis
